![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 20, 2016 1:54:48 PM
The pps of this company does reek of manipulation. And I do agree that the cc created more questions than answers. I also agree that the AGM will be very eventful with all of the outstanding questions, and need for further details about the OEM, and financing going forward. It's a hell of a device and again, if there were any flaws or omissions in functionality, we would have heard about it during or after SAGES.
Is it still possible to submit a lesser version for CE mark and begin to sell outside US, sooner than when the OEM partnered version is made available? Or use the OEM version with fewer indications and go for V1.2 when fully completed? Why not sell the OEM version with 2 to 4 main indications, and provide additional indications as V1.2 as a chargeable upgrade? Brings the product before the FDA sooner, and to market quicker. Just a thought.
JMO.
Respectfully,
BK
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM